Investing.com - MorphoSys ADR reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
MorphoSys ADR announced earnings per share of $-0.5707 on revenue of $41.04M. Analysts polled by Investing.com anticipated EPS of $-0.5949 on revenue of $41.23M.
MorphoSys ADR shares are up 11% from the beginning of the year, still down 60.62% from its 52 week high of $34.99 set on August 5, 2020. They are under-performing the STOXX 600 which is up 16.26% from the start of the year.
MorphoSys ADR follows other major Healthcare sector earnings this month
MorphoSys ADR's report follows an earnings beat by J&J on July 21, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar